EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.7.1.191 | COVID-19 |
33357725 |
Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019. |
therapeutic application
unassigned |
2
0 |
| 2.7.1.191 | COVID-19 |
33511147 |
Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19. |
unassigned |
0 |
| 2.7.1.191 | COVID-19 |
33587321 |
Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from Radix Scutellariae using angiotensin-converting enzyme II/cell membrane chromatography. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
3
4
0 |
| 2.7.1.191 | COVID-19 |
33879756 |
Single-cell analysis of angiotensin-converting enzyme II expression in human kidneys and bladders reveals a potential route of 2019 novel coronavirus infection. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
3
3
4 |
| 2.7.1.191 | COVID-19 |
33991451 |
Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19. |
causal interaction
ongoing research
unassigned |
4
4
0 |
| 2.7.1.191 | COVID-19 |
34517046 |
Coronavirus disease-19 and the gut-lung axis. |
unassigned |
0 |
| 2.7.1.191 | Dental Caries |
28821551 |
Coordinated Regulation of the EII(Man) and fruRKI Operons of Streptococcus mutans by Global and Fructose-Specific Pathways. |
unassigned |
0 |
| 2.7.1.191 | Endocarditis |
26984142 |
Genome-wide screening identifies PTS permease BepA to be involved in Enterococcus faecium endocarditis and biofilm formation. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 2.7.1.191 | Heart Failure |
16962475 |
Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 2.7.1.191 | Heart Failure |
31833870 |
Bioanalytical Assessment of Plasma Concentrations of Angiotensin-Converting Enzyme II Inhibitors and Angiotensin Receptor Blockers: A Pilot Study Among Patients Hospitalized With Acute Heart Failure. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
2
3
3
2 |
